Renal cell carcinoma chest x ray: Difference between revisions
Jump to navigation
Jump to search
Farima Kahe (talk | contribs) No edit summary |
Farima Kahe (talk | contribs) No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
There are no x-ray findings associated with renal cell carcinoma. However, an x-ray may be helpful in the diagnosis of pulmonary metastasis of renal cell carcinoma. | There are no x-ray findings associated with renal cell carcinoma. However, an x-ray may be helpful in the diagnosis of [[pulmonary metastasis]] of renal cell carcinoma. | ||
==Chest x ray== | ==Chest x ray== | ||
There are no x-ray findings associated with renal cell carcinoma. However, an x-ray may be helpful in the diagnosis of pulmonary metastasis of renal cell carcinoma. | There are no x-ray findings associated with renal cell carcinoma. However, an x-ray may be helpful in the diagnosis of [[pulmonary metastasis]] of renal cell carcinoma. | ||
The following guidelines of the American Urological Association in 2013 state the following regarding the use of chest xray in renal cell carcinoma: | The following guidelines of the American Urological Association in 2013 state the following regarding the use of chest xray in renal cell carcinoma: | ||
{| | {| style="border-collapse:collapse; text-align:left;" cellpadding="5" border="1" align="center" | ||
|+ '''''Use of Chest Xray in Renal Cell Carcinoma<ref name="pmid23665399">{{cite journal| author=Donat SM, Diaz M, Bishoff JT, Coleman JA, Dahm P, Derweesh IH et al.| title=Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline. | journal=J Urol | year= 2013 | volume= 190 | issue= 2 | pages= 407-16 | pmid=23665399 | doi=10.1016/j.juro.2013.04.121 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23665399 }} </ref>''''' | |+ '''''Use of Chest Xray in Renal Cell Carcinoma<ref name="pmid23665399">{{cite journal| author=Donat SM, Diaz M, Bishoff JT, Coleman JA, Dahm P, Derweesh IH et al.| title=Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline. | journal=J Urol | year= 2013 | volume= 190 | issue= 2 | pages= 407-16 | pmid=23665399 | doi=10.1016/j.juro.2013.04.121 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23665399 }} </ref>''''' | ||
! colspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |'''Use of Chest-Xray'''|| | ! colspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |'''Use of Chest-Xray'''|| colspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" ! + |'''Evidence Strength''' | ||
|- | |- | ||
| bgcolor="#ececec"|'''Low Risk Patient (pT1, N0, Nx)''' || Yearly chest x-ray to assess for pulmonary metastases for 3 years and only as clinicall indicated beyond that time period || C | | bgcolor="#ececec" |'''Low Risk Patient (pT1, N0, Nx)''' || Yearly chest x-ray to assess for pulmonary metastases for 3 years and only as clinicall indicated beyond that time period || C | ||
|- | |- | ||
| bgcolor="#ececec"|'''Moderate to High Risk Patients (pT2-4N0 Nx or any stage N+)''' ||Chest-xray to be performed every 6 months following a baseline CT or MRI (within 3 to 6 months post-surgery) for at least 3 years and annually thereafter to year 5. Imaging, including chest-xray is warranted by clinical symptoms suggestive of recurrence of metastatic spread. Any imaging, including chest x-ray beyond 5 years may be performed at the discretion of the clinician for moderate to high risk patients || C | | bgcolor="#ececec" |'''Moderate to High Risk Patients (pT2-4N0 Nx or any stage N+)''' ||Chest-xray to be performed every 6 months following a baseline CT or MRI (within 3 to 6 months post-surgery) for at least 3 years and annually thereafter to year 5. Imaging, including chest-xray is warranted by clinical symptoms suggestive of recurrence of metastatic spread. Any imaging, including chest x-ray beyond 5 years may be performed at the discretion of the clinician for moderate to high risk patients || C | ||
|- | |- | ||
| bgcolor="#ececec"|'''Active surveillance''' || Patients with biopsy-proven renal cell carcinoma or tumor with oncocytic features should undergo an annual chest-xray to assess for pulmonary metastases || C | | bgcolor="#ececec" |'''Active surveillance''' || Patients with biopsy-proven renal cell carcinoma or tumor with oncocytic features should undergo an annual chest-xray to assess for pulmonary metastases || C | ||
|- | |- | ||
| bgcolor="#ececec"|'''Patients undergoing ablative procedures with biopy-proven low-risk renal cell carcinoma, oncocytoma, tumor with oncocytic features, non-diagnostic biopsy, or no previous biopsy ''' || Annual chest x-ray for 5 years. Imaging beyond 5 years based on individual patient risk factors and determination of treatment success || Expert opinion | | bgcolor="#ececec" |'''Patients undergoing ablative procedures with biopy-proven low-risk renal cell carcinoma, oncocytoma, tumor with oncocytic features, non-diagnostic biopsy, or no previous biopsy ''' || Annual chest x-ray for 5 years. Imaging beyond 5 years based on individual patient risk factors and determination of treatment success || Expert opinion | ||
|} | |} | ||
<sup><center>Adapted from Donat SM et al. Follow-up for clinically localized renal neoplasms: AUA guideline. ''J Urol''. 2013; 190(2):407-16. </center></sup> | <sup><center>Adapted from Donat SM et al. Follow-up for clinically localized renal neoplasms: AUA guideline. ''J Urol''. 2013; 190(2):407-16. </center></sup> | ||
Latest revision as of 16:45, 11 December 2018
|
Renal cell carcinoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Renal cell carcinoma chest x ray On the Web |
|
American Roentgen Ray Society Images of Renal cell carcinoma chest x ray |
|
Risk calculators and risk factors for Renal cell carcinoma chest x ray |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Farima Kahe M.D. [2]
Overview
There are no x-ray findings associated with renal cell carcinoma. However, an x-ray may be helpful in the diagnosis of pulmonary metastasis of renal cell carcinoma.
Chest x ray
There are no x-ray findings associated with renal cell carcinoma. However, an x-ray may be helpful in the diagnosis of pulmonary metastasis of renal cell carcinoma.
The following guidelines of the American Urological Association in 2013 state the following regarding the use of chest xray in renal cell carcinoma:
| Use of Chest-Xray | Evidence Strength | ||
|---|---|---|---|
| Low Risk Patient (pT1, N0, Nx) | Yearly chest x-ray to assess for pulmonary metastases for 3 years and only as clinicall indicated beyond that time period | C | |
| Moderate to High Risk Patients (pT2-4N0 Nx or any stage N+) | Chest-xray to be performed every 6 months following a baseline CT or MRI (within 3 to 6 months post-surgery) for at least 3 years and annually thereafter to year 5. Imaging, including chest-xray is warranted by clinical symptoms suggestive of recurrence of metastatic spread. Any imaging, including chest x-ray beyond 5 years may be performed at the discretion of the clinician for moderate to high risk patients | C | |
| Active surveillance | Patients with biopsy-proven renal cell carcinoma or tumor with oncocytic features should undergo an annual chest-xray to assess for pulmonary metastases | C | |
| Patients undergoing ablative procedures with biopy-proven low-risk renal cell carcinoma, oncocytoma, tumor with oncocytic features, non-diagnostic biopsy, or no previous biopsy | Annual chest x-ray for 5 years. Imaging beyond 5 years based on individual patient risk factors and determination of treatment success | Expert opinion | |
References
- ↑ Donat SM, Diaz M, Bishoff JT, Coleman JA, Dahm P, Derweesh IH; et al. (2013). "Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline". J Urol. 190 (2): 407–16. doi:10.1016/j.juro.2013.04.121. PMID 23665399.